Cargando…
Patient-reported data informing early benefit assessment of rare diseases in Germany: A systematic review
BACKGROUND: Since the implementation of the Regulation on Patient Integration (2003), the Act on the Reorganization of the Pharmaceutical Market (2011), and the Patient Rights Law (2013), the inclusion of patient perspectives has been further anchored in the German early benefit assessment process....
Autores principales: | Babac, Ana, Damm, Kathrin, Graf von der Schulenburg, J.-Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909645/ https://www.ncbi.nlm.nih.gov/pubmed/31832812 http://dx.doi.org/10.1186/s13561-019-0251-9 |
Ejemplares similares
-
Comparison of different approaches applied in Analytic Hierarchy Process – an example of information needs of patients with rare diseases
por: Pauer, Frédéric, et al.
Publicado: (2016) -
Integrating patient perspectives in medical decision-making: a qualitative interview study examining potentials within the rare disease information exchange process in practice
por: Babac, Ana, et al.
Publicado: (2019) -
Shaping an Effective Health Information Website on Rare Diseases Using a Group Decision-Making Tool: Inclusion of the Perspectives of Patients, Their Family Members, and Physicians
por: Babac, Ana, et al.
Publicado: (2017) -
Benefit assessment in Germany: implications for price discounts
por: Theidel, Ulrike, et al.
Publicado: (2016) -
Measuring patients’ priorities using the Analytic Hierarchy Process in comparison with Best-Worst-Scaling and rating cards: methodological aspects and ranking tasks
por: Schmidt, Katharina, et al.
Publicado: (2016)